Showing results (71-80 of 573) with videos related to
Sort By:
Pageof 58
Therapeutic Advances in Infectious Disease|July 22, 2021
Risk factors for triatominae infestation in a municipality of ColombiaGabriel Parra-Henao, Sandra P Garzón-Jiménez, Yuly Bernal-Rosas, et al.Therapeutic Advances in Infectious Disease|May 20, 2022
The use of technology-based adherence monitoring in the treatment of hepatitis C virusYeba H Adje, Kristina M Brooks, Jose R Castillo-Mancilla, et al.Therapeutic Advances in Infectious Disease|July 15, 2021
An exercise intervention alters stool microbiota and metabolites among older, sedentary adultsKristine M Erlandson, Jay Liu, Rachel Johnson, et al.Therapeutic Advances in Infectious Disease|May 26, 2023
Donepezil-associated survival benefits among Alzheimer's disease patients are retained but not enhanced during COVID-19 infectionsElizabeth A Edmiston, Taissa A Bej, Brigid Wilson, et al.Therapeutic Advances in Infectious Disease|April 28, 2023
A dengue vaccine whirlwind updateRuwandi Kariyawasam, Mark Lachman, Saniya Mansuri, et al.Therapeutic Advances in Infectious Disease|April 28, 2023
PrEP policy implementation gaps and opportunities in Latin America and the Caribbean: a scoping reviewLuke Murphy, Andrea Bowra, Ellithia Adams, et al.Therapeutic Advances in Infectious Disease|May 26, 2018
Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infectionsAshley F Soule, Sarah B Green, Lisa M BlanchetteTherapeutic Advances in Infectious Disease|April 18, 2018
CorrigendumTherapeutic Advances in Infectious Disease|March 24, 2022
Risk factors and spatial analysis for domiciliary infestation with the Chagas disease vector Triatoma venosa in ColombiaOscar Quiros-Gomez, Ángela Segura-Cardona, Piedad Agudelo Flórez, et al.Therapeutic Advances in Infectious Disease|August 27, 2019
Clostridioides difficile therapeutics: guidelines and beyondRobert Orenstein, Roberto L PatronPageof 58